Covid-19 Predictors: Safety of Gynecological Oncology Patients Undergoing Systemic Cancer Therapy

COVID-19-Prädiktoren: Klinische Studie Zur Sicherheit Von Gynäkologisch Onkologischen Patientinnen Unter Onkologischer Systemtherapie - CO-SI-ONKO-Studie

We designed a monocenter prospective cohort study using PROM via app and remote monitoring via pho-toplethysmography (PPG). The application of these technologies enables an early detection of infections and therefore initiation of medical interventions. The study is conducted as feasibility analysis; primary endpoints are adherence (according to wearing time) and technical robustness.

Inclusion Criteria:

• gynecological cancer
• indication for systemic cancer therapy
• patients who are legally competent and able to understand and follow instructions of the study staff
• present informed consent

Exclusion Criteria:

• no use if internet or applications
• persons who are in a dependency or employment relationship with the study center
• positive proof of COVID-19
• affection of the external auditory canal